Ascentage Pharma Group (AAPG) - Company Cash Volume

Graphic logo of ascentage.com (AAPG)

The cash-on-hand metric visualizes the liquidity of Ascentage Pharma Group (AAPG), where 0.16 defines the current value of the indicator. High expenditures on thermal containers ensure the preservation of oncology drugs during delivery. The strategy is based on developing targeted medicines for the US and Chinese markets, thereby reducing patent risks. The seamless cross-border movement of biosamples is guaranteed through partnerships with vetted medical couriers.

AAPG - Ascentage Pharma Group International Company Cash Position over the range 01/25/2025 - 11/21/2026

Financial and market metric breakdowns for Ascentage Pharma Group International (AAPG)

- current price and projected stock value:
- market capitalization indicators:
Fundamental company valuation:Ascentage Pharma Group
Product sample of Ascentage Pharma

Through partnerships with global distributors, Ascentage Pharma Group is optimizing promotion expenses, which helps preserve liquidity for the development of anti-tumor drugs. This metric measures the volume of immediately available funds to cover operational gaps, while the current cash level provides a real-time assessment of the balance between R&D investments and the company's financial stability.

Direct competitors

Company Cash Volume ONC|HALO - Company Cash Reserve|Revolution Medicines - Company Cash on Hand|CG Oncology Inc (CGON) - Company Cash Reserve|URGN - Company Cash Funds|Bicara Bio - Company Total Cash Amount|PSNL: Company Cash Volume|Company Cash and Cash Equivalents ERAS|Company Cash on Hand DCTH|Company Cash Reserve Y-mAbs Therapeutics Inc YMAB|Company Cash Volume AURA|CADL (Candel Therapeutics, Inc.) - Company Cash Balance|Company Cash Funds Accuray Inc ARAY|Company Liquid Assets SELLAS Life Sciences Group Inc. (SLS)|actuatetherapeutics.com - Company Cash Volume|Company Cash Reserve Citius Oncology|HURA: Company Cash Volume|Company Total Cash Volume TARA (Protara)|FATE (fatetherapeutics.com) - Company Cash Volume|Company Cash Reserve Aadi Bioscience WHWK|Company Cash Volume TCRX|CSBR - Company Cash Reserve|XBiotech - Company Cash on Hand|CEL-SCI Corporation (CVM) - Company Cash Reserve|OSTX - Company Cash Funds|Company Cash Reserve Radiopharm Theranostics Ltd|ARTV (artivabio.com) - Company Cash on Hand|ANL (Adlai Nortye Ltd) - Company Cash Funds|Company Cash on Hand VERU|Tempest Therapeutics (TPST) - Company Liquid Assets|Company Cash Volume XLO|Company Cash on Hand Renovaro RENB|Company Cash Volume MURA (Mural Oncology PLC)|KAPA - Company Cash on Hand|OnKure Therapeutics - Company Cash Volume|w2.cytomed.sg - Company Total Cash Amount|Curis Corp (CRIS) - Company Cash Funds|Company Cash Reserve Apollomics Corp (APLM)|Company Cash Funds Tharimmune|Company Cash Volume advanbiomed.com|Company Cash Funds Genprex, Inc (GNPX)|Company Liquid Assets Calidi Biotherapeutics, Inc.|Company Cash Volume SBFM (Sunshine Biopharma Inc.)|XBIO - Company Cash on Hand|SLRX: Company Cash on Hand|Company Cash Balance PPBT (Purple Biotech Ltd.)|AONC: Company Cash Volume|Company Cash Reserve BeOne Medicines (BGNE)|Company Cash Funds Checkpoint Therapeutics, Inc.|Company Cash on Hand Elevation Oncology (ELEV)|Company Cash Funds iCAD Corp (ICAD)|Company Cash on Hand Ikena IKNA|Company Cash Volume NTBL (notablelabs.com)|VIRX - Company Cash on Hand|MOR: Company Cash on Hand|NAYA - Company Cash Volume|Ascentage Pharma (AAPGV) - Company Cash Funds